Cargando…
P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171470/ http://dx.doi.org/10.1097/01.HS9.0000936256.84340.a7 |
_version_ | 1785039423408177152 |
---|---|
author | van de Donk, N. Cortes-Selva, D. Casneuf, T. Vishwamitra, D. Stein, S. Perova, T. Ramos, E. Van Steenbergen, L. Boominathan, R. Lau, O. Davis, C. Banerjee, A. Stephenson, T. Uhlar, C. Kobos, R. Goldberg, J. Pei, L. Trancucci, D. Girgis, S. Lin, S.X.W. Wu, L.S. Moreau, P. Usmani, S. Bahlis, N.J. Verona, R. |
author_facet | van de Donk, N. Cortes-Selva, D. Casneuf, T. Vishwamitra, D. Stein, S. Perova, T. Ramos, E. Van Steenbergen, L. Boominathan, R. Lau, O. Davis, C. Banerjee, A. Stephenson, T. Uhlar, C. Kobos, R. Goldberg, J. Pei, L. Trancucci, D. Girgis, S. Lin, S.X.W. Wu, L.S. Moreau, P. Usmani, S. Bahlis, N.J. Verona, R. |
author_sort | van de Donk, N. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10171470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101714702023-05-11 P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) van de Donk, N. Cortes-Selva, D. Casneuf, T. Vishwamitra, D. Stein, S. Perova, T. Ramos, E. Van Steenbergen, L. Boominathan, R. Lau, O. Davis, C. Banerjee, A. Stephenson, T. Uhlar, C. Kobos, R. Goldberg, J. Pei, L. Trancucci, D. Girgis, S. Lin, S.X.W. Wu, L.S. Moreau, P. Usmani, S. Bahlis, N.J. Verona, R. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171470/ http://dx.doi.org/10.1097/01.HS9.0000936256.84340.a7 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Poster van de Donk, N. Cortes-Selva, D. Casneuf, T. Vishwamitra, D. Stein, S. Perova, T. Ramos, E. Van Steenbergen, L. Boominathan, R. Lau, O. Davis, C. Banerjee, A. Stephenson, T. Uhlar, C. Kobos, R. Goldberg, J. Pei, L. Trancucci, D. Girgis, S. Lin, S.X.W. Wu, L.S. Moreau, P. Usmani, S. Bahlis, N.J. Verona, R. P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title | P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_full | P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_fullStr | P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_full_unstemmed | P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_short | P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_sort | p32 majestec-1: correlative analyses of teclistamab, a b-cell maturation antigen (bcma) x cd3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (rrmm) |
topic | Poster |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171470/ http://dx.doi.org/10.1097/01.HS9.0000936256.84340.a7 |
work_keys_str_mv | AT vandedonkn p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT cortesselvad p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT casneuft p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT vishwamitrad p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT steins p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT perovat p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT ramose p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT vansteenbergenl p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT boominathanr p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT lauo p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT davisc p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT banerjeea p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT stephensont p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT uhlarc p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT kobosr p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT goldbergj p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT peil p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT trancuccid p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT girgiss p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT linsxw p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT wuls p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT moreaup p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT usmanis p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT bahlisnj p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT veronar p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm |